参脉注射液对慢性阻塞性肺病急性加重期患者红细胞免疫功能的影响  

Curative effects of injections of shenmai in acute chronic obstructive pulmonary disease

作　　者：李小惠[1] 周雨田[1] 李蔚[1] 王凤琼[1] 刘佳芳[1] 

机构地区：[1]四川省人民医院干部科老年呼吸病房,四川成都610072

出　　处：《四川医学》2010年第8期1040-1041,共2页Sichuan Medical Journal

基　　金：四川省卫生厅科研资助项目(编号:303.005.002.178.003)

摘　　要：目的探讨参麦注射液配合常规疗法治疗慢性阻塞性肺病(COPD)急性发作的疗效及其对红细胞免疫功能的影响。方法将80例COPD急性发作期患者随机分为常规疗法组和联用参麦治疗组,联用参麦治疗组在常规疗法的基础上联用参麦注射液治疗。观察两组红细胞免疫功能的变化。结果联用参麦治疗组治疗后C3bRR、RFER较对照组升高明显,而ICR and RFIR明显低于对照组。结论在常规疗法的基础上联用参麦注射液治疗COPD急性发作能改善红细胞免疫功能。Objective To investigate the effect of shenmai injection（SMI）on patients of AECOPD.Methods 80 patients were divided into two groups,the control group treated with conventional medicine and the therapy group treated with conventional medicine plus SMI.The indices including red blood cell C3bRR、RFER、ICR and RFIR.Results The level of C3bRR、RFER in therapy group is higher than control group,The level of ICR and RFIR in therapy group is lower than control group.Conclusion SMI has the effecting regulating immune functon in patients with COPD.

关 键 词：慢性阻塞性肺病急性加重期 参麦注射液 红细胞免疫功能 

分 类 号：R259[医药卫生—中西医结合]